Medicare Spending and Potential Savings on Brand-Name Drugs With Available Generic Substitutes Excluded by 2 Large Pharmacy Benefit Managers, 2012 Through 2015
- PMID: 29340562
- PMCID: PMC5876838
- DOI: 10.1001/jamainternmed.2017.8016
Medicare Spending and Potential Savings on Brand-Name Drugs With Available Generic Substitutes Excluded by 2 Large Pharmacy Benefit Managers, 2012 Through 2015
Abstract
This study uses Medicare Part D drug utilization and spending data to estimate potential Part D program and beneficiary savings on brand-name medications excluded by pharmacy benefit managers for which generic substitutes are available.
Conflict of interest statement
References
-
- Hoadley J, Cubanski J, Neuman T Medicare Part D in 2016 and trends over time. Henry J. Kaiser Family Foundation website. Published September 16, 2016. https://www.kff.org/report-section/medicare-part-d-in-2016-and-trends-ov... Accessed July 20, 2017.
-
- Centers for Medicare and Medicaid Services 2015 Medicare Drug Spending Data. https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Tren.... Accessed July 20, 2017.
-
- Congressional Budget Office The Budget and Economic Outlook: 2015-2025. https://www.cbo.gov/sites/default/files/114th-congress-2015-2016/reports.... Accessed July 20, 2017.
-
- Health Strategies Group Pharmacy Benefit Managers. http://www.healthstrategies.com/sites/default/files/agendas/2015_PBM_Res.... Accessed July 20, 2017.
-
- Johansen ME, Richardson C. Estimation of potential savings through therapeutic substitution. JAMA Intern Med. 2016;176(6):769-775. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical